Iovance Biotherapeutics, Inc.


Iovance Biotherapeutics, Inc. Stock Quote
$41.32 $2.51 6.5%
Price as of December 1, 2020, 9:00 p.m. EST View Interactive IOVA Charts

Iovance Biotherapeutics, Inc.

Interactive Chart

News & Analysis: Iovance Biotherapeutics, Inc.


Market Moves


Is Iovance Biotherapeutics a Buy?

After rumors swirled about a potential acquisition, it now appears the biopharma is transitioning to commercial operations as a standalone company.

Here's Why Agenus Tumbled Today

Results from an experimental combination therapy were impressive, but they might not be impressive enough.

2 Top Biotech Stocks to Buy Right Now

These two companies are pushing the envelope of immunotherapies by developing unique cell types. Each has promising results for investors to consider.